ANIP Shares Outstanding History
Below is a table of the ANIP shares outstanding history going back to 7/18/2013:

Date ANIP Shares Outstanding
7/18/20130.00B
7/31/20139.54M
10/31/20139.48M
2/14/20149.64M
5/2/201411.28M
8/1/201411.31M
11/3/201411.32M
2/12/201511.39M
5/1/201511.41M
7/29/201511.45M
10/28/201511.49M
2/12/201611.45M
4/28/201611.49M
7/28/201611.51M
10/27/201611.58M
2/21/201711.59M
4/27/201711.64M
7/27/201711.64M
10/26/201711.64M
2/20/201811.65M
5/1/201811.79M
7/31/201811.82M
10/30/201811.85M
2/20/201911.85M
5/1/201912.04M
7/31/201912.09M
10/30/201912.08M
2/20/202012.10M
4/30/202012.33M
7/31/202012.30M
10/29/202012.35M
3/2/202112.35M
4/30/202112.73M

Also see: ANIP Market Cap History
ANIP YTD Return
ANIP Historical Shares Outstanding:
+15.76% CAGR
ANIP Historical Shares Outstanding: +15.76% CAGR

Mouse over chart for data details
7/18/2013 ...4/30/2021
ANI Pharmaceuticals is a pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include, among others: Arimidex, which is used for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer; Erythromycin Ethylsuccinate, which is used to treat infections caused by susceptible strains of designated organisms for selected diseases; Diphenoxylate Hydrochloride and Atropine Sulfate, which is used as an adjunctive therapy in the management of diarrhea; and Etodolac, which is used to treat mild to moderate pain caused by osteoarthritis and rheumatoid arthritis. We show 33 historical shares outstanding datapoints in our coverage of ANIP's shares outstanding history.

Understanding the changing numbers of ANIP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ANIP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ANIP by allowing them to research ANIP shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ANIP:
ANIP SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ANI Pharmaceuticals (ANIP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ANTH Shares Outstanding History
APEN Shares Outstanding History
APLS Shares Outstanding History
APRI Shares Outstanding History
APVO Shares Outstanding History
AQB Shares Outstanding History
AQXP Shares Outstanding History
ARA Shares Outstanding History
ARAY Shares Outstanding History
ARDM Shares Outstanding History
More Healthcare companies »

 

ANIP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.